Aytu BioPharma, Inc. (AYTU)

USD 1.31

(-1.88%)

Annual Balance Sheets

(In USD)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 118.09 Million 136.46 Million 137.62 Million 265.66 Million 152.83 Million 34.72 Million
Total Current Assets 61.89 Million 72.83 Million 59.92 Million 105.23 Million 74.96 Million 15.43 Million
Cash And Short Term Investments 20 Million 22.98 Million 19.36 Million 49.64 Million 48.08 Million 11.04 Million
Cash and Cash Equivalents 20 Million 22.98 Million 19.36 Million 49.64 Million 48.08 Million 11.04 Million
Short Term Investments - - - - - -
Net Receivables 23.61 Million 28.93 Million 21.71 Million 28.17 Million 5.17 Million 1.74 Million
Inventory 12.63 Million 11.99 Million 10.84 Million 16.33 Million 9.99 Million 1.44 Million
Other Current Assets 5.63 Million 868 Thousand 633 Thousand 1.03 Million 5.74 Million 1.2 Million
Total Non-Current Assets 56.2 Million 63.63 Million 77.69 Million 160.43 Million 77.87 Million 19.28 Million
Net PPE 1.52 Million 3.86 Million 6.29 Million 8.7 Million 892.6 Thousand 203.73 Thousand
Good Will And Intangible Assets 52.45 Million 58.97 Million 70.63 Million 151.26 Million 76.94 Million 19.08 Million
Good Will - - - 65.8 Million 28.09 Million -
Intangible Assets 52.45 Million 58.97 Million 70.63 Million 85.46 Million 48.85 Million 19.08 Million
Long-Term Investments -762 Thousand -1.37 Million - -10.9 Million -1.8 Million -
Tax Assets 762 Thousand 1.37 Million - 10.9 Million 1.8 Million -
Other Non Current Assets 2.22 Million 792 Thousand 766 Thousand 465 Thousand 32.98 Thousand 2200.00
Other Assets - - - - - -
Total Liabilities 90.37 Million 97.1 Million 91.53 Million 128.1 Million 57.82 Million 27.63 Million
Total Current Liabilities 62.22 Million 69.01 Million 64.44 Million 109.43 Million 28.3 Million 5.37 Million
Account Payables 10.44 Million 13.47 Million 10.98 Million 19.25 Million 11.82 Million 2.29 Million
Tax Payables - - - - 175 Thousand -
Short Term Debt 4.25 Million 1.64 Million 3.9 Million 25.54 Million 1.28 Million -
Deferred Revenue 38.57 Million 46.79 Million - 57.23 Million 339.33 Thousand -
Other Current Liabilities 8.96 Million 7.09 Million 49.54 Million 7.4 Million 14.86 Million 3.07 Million
Total Non Current Liabilities 28.15 Million 28.09 Million 27.08 Million 18.66 Million 29.51 Million 22.26 Million
Long-Term Debt 10.87 Million 14.71 Million 14.27 Million 2.8 Million 725.37 Thousand -
Deferred Revenue Non Current -762 Thousand -1.37 Million - -11.15 Million -1.8 Million -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 17.27 Million 13.37 Million 12.81 Million 15.85 Million 28.78 Million 22.26 Million
Other Liabilities - - - - - -
Total Equity 27.71 Million 39.35 Million 46.09 Million 137.56 Million 95.01 Million 7.08 Million
Stock Holders Equity 27.71 Million 39.35 Million 46.09 Million 137.56 Million 95.01 Million 7.08 Million
Common Stock 1000.00 1000.00 4000.00 3000.00 12.58 Thousand 1754.00
Retained Earnings -319.97 Million -304.12 Million -288.47 Million -178.29 Million -120.01 Million -106.38 Million
Accumulated other comprehensive income - - - - - -
Common Stock Equity 27.71 Million 39.35 Million 46.09 Million 137.56 Million 95.01 Million 7.08 Million
Capital Lease Obligation 1.28 Million 832 Thousand 2.17 Million 3.56 Million 1.02 Million -
Total Investments -762 Thousand -1.37 Million - -10.9 Million -1.8 Million -
Total Debt 15.12 Million 16.36 Million 18.18 Million 28.34 Million 2 Million -
Net Debt -4.87 Million -6.62 Million -1.17 Million -21.3 Million -46.07 Million -11.04 Million

Balance Sheet Charts